SCHWARTZ, PETER
 Distribuzione geografica
Continente #
NA - Nord America 16.666
AS - Asia 13.438
EU - Europa 11.349
SA - Sud America 1.560
AF - Africa 208
OC - Oceania 43
Continente sconosciuto - Info sul continente non disponibili 20
Totale 43.284
Nazione #
US - Stati Uniti d'America 16.370
CN - Cina 8.363
SG - Singapore 2.799
IE - Irlanda 2.598
UA - Ucraina 2.021
DE - Germania 1.756
HK - Hong Kong 1.318
BR - Brasile 1.282
FI - Finlandia 1.187
RU - Federazione Russa 1.095
SE - Svezia 899
IT - Italia 785
GB - Regno Unito 530
VN - Vietnam 343
CA - Canada 197
FR - Francia 179
IN - India 132
AR - Argentina 105
BD - Bangladesh 88
MX - Messico 68
JP - Giappone 65
IQ - Iraq 56
ZA - Sudafrica 56
NL - Olanda 52
EC - Ecuador 50
AT - Austria 48
BE - Belgio 46
ES - Italia 39
MA - Marocco 38
PL - Polonia 38
TR - Turchia 32
CO - Colombia 31
MU - Mauritius 31
PK - Pakistan 28
KE - Kenya 27
ID - Indonesia 26
VE - Venezuela 26
AU - Australia 25
PY - Paraguay 23
IR - Iran 22
JO - Giordania 20
CL - Cile 18
SA - Arabia Saudita 18
UZ - Uzbekistan 18
EU - Europa 17
NZ - Nuova Zelanda 16
AE - Emirati Arabi Uniti 15
EG - Egitto 14
AZ - Azerbaigian 13
PE - Perù 10
AL - Albania 9
DZ - Algeria 9
NP - Nepal 9
UY - Uruguay 9
CZ - Repubblica Ceca 8
IL - Israele 8
OM - Oman 8
TN - Tunisia 8
BG - Bulgaria 7
DK - Danimarca 7
LT - Lituania 7
LV - Lettonia 7
BO - Bolivia 6
CR - Costa Rica 6
SN - Senegal 6
CH - Svizzera 5
HU - Ungheria 5
KR - Corea 5
KW - Kuwait 5
KZ - Kazakistan 5
PS - Palestinian Territory 5
RO - Romania 5
DO - Repubblica Dominicana 4
ET - Etiopia 4
GE - Georgia 4
HN - Honduras 4
KG - Kirghizistan 4
MY - Malesia 4
NI - Nicaragua 4
PH - Filippine 4
QA - Qatar 4
BH - Bahrain 3
BW - Botswana 3
GR - Grecia 3
LB - Libano 3
NO - Norvegia 3
PA - Panama 3
TT - Trinidad e Tobago 3
AM - Armenia 2
CG - Congo 2
GA - Gabon 2
JM - Giamaica 2
LK - Sri Lanka 2
LU - Lussemburgo 2
PR - Porto Rico 2
TG - Togo 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
Totale 43.259
Città #
Chandler 2.644
Dublin 2.593
Jacksonville 2.590
Nanjing 2.101
Dallas 1.469
Hong Kong 1.312
Ashburn 1.160
Singapore 1.149
Beijing 946
Boardman 902
Nanchang 853
Princeton 640
Lawrence 603
Shenyang 600
Changsha 575
Hebei 571
Wilmington 559
Jiaxing 511
Munich 482
Helsinki 422
Medford 408
Los Angeles 349
Tianjin 331
Hangzhou 324
Moscow 232
Redondo Beach 224
Buffalo 202
Ann Arbor 195
Milan 148
Woodbridge 148
New York 139
Shanghai 130
Ho Chi Minh City 117
São Paulo 116
Verona 115
Norwalk 112
Toronto 74
Hanoi 69
Houston 69
Nuremberg 63
Seattle 63
Tokyo 63
Fairfield 61
Kunming 58
Pavia 53
Zhengzhou 53
Guangzhou 52
Mcallen 52
Brooklyn 51
Des Moines 47
Washington 47
Falkenstein 44
Jinan 44
Falls Church 42
Chicago 40
San Francisco 39
Montréal 37
Ningbo 36
Brussels 35
Santa Clara 35
Warsaw 35
Johannesburg 33
Turku 32
Boston 31
Rome 30
Stockholm 30
Chennai 29
Montreal 29
Rio de Janeiro 29
The Dalles 29
Baghdad 28
Belo Horizonte 28
Brasília 28
London 27
Denver 26
Orem 26
Nairobi 25
Atlanta 24
Fuzhou 24
Curitiba 23
Dearborn 23
Mexico City 21
Phoenix 21
Secaucus 21
Vienna 21
Amman 20
Frankfurt am Main 20
Pune 20
Changchun 19
Columbus 19
Lanzhou 19
Manchester 19
Charlotte 18
Guayaquil 18
Orange 18
San Jose 18
Taizhou 18
Tashkent 18
San Genesio Ed Uniti 17
Tappahannock 17
Totale 28.150
Nome #
[A new experimental model for the study of arrhythmias dependent on the interaction between myocardial ischemia and sympathetic hyperactivity. I. Effects of phosphocreatinine]. 286
[Changes of a reflex nature in the cardiac sympathetic activity induced with increases of arterial pressure in spinal animals]. 252
[Idiopathic syndrome of the long QT interval--the need for a prospective study]. 245
[Legal implications of medical guidelines. A Task Force of the European Society of Cardiology]. 241
Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions. 240
Identificazione di microRNA circolanti specificatamente sovra espressi in corso di infarto miocardico acuto. 236
Calcio antagonisti e aritmie da riperfusione miocardica 197
Pathophysiological rationale for cardiac vagal denervation in the treatment of atrial fibrillation 146
[Activity of afferent cardiac vagal fibers during experimental myocardial ischemia]. 139
Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death. 139
[Activity of preganglionic sympathetic single fibers during experimental coronary occlusion]. 138
[Infant mortality and sudden crib death in Lombardy]. 129
PREDESTINATION: PRimary vEntricular fibrillation and suDden dEath during a firST myocardIal iNfArcTION: Genetic basis. 127
Long QT and short QT syndromes. 126
A KCNH2 branch point mutation causing aberrant splicing contributes to an explanation of genotype-negative long QT syndrome. 123
[Neonatal electrocardiography and the sudden infant death syndrome (SIDS)]. 122
Identification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in long-QT syndrome. 121
Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice 120
[Electrophysiologic features of the modulation of ATP-dependent potassium channels]. 119
[Long QT syndrome and Brugada syndrome: 2 aspects of the same disease?]. 118
Spectrum and prevalence of mutations involving BrS1-12 susceptibility genes in a cohort of unrelated patients referred for Brugada Syndrome genetic testing: implications for genetic testing. 118
[Idiopathic ventricular fibrillation: from a collection of clinical cases to a prospective evaluation. The U-CARE Steering Committee. Unexplained Cardiac Arrest Registry of Europe]. 118
Aspetti elettrofisiologici della modulazione dei canali del potassio ATP-dipendenti 116
[Cardio-cardiac sympathico-vagal reflex]. 115
FGF12 is a candidate Brugada syndrome locus. 115
[Sympathetic reflex induced by experimental coronary occlusion]. 114
[Study of preganglionic sympathetic single fibers in relation to various physiologic and pathologic stimuli]. 114
25th anniversary of the International Long-QT Syndrome Registry: an ongoing quest to uncover the secrets of long-QT syndrome. 114
Effect of Considering the Relatives' Quality of Life in Cost-Utility Studies 113
Antifibrillatory efficacy of ersentilide, a novel beta-adrenergic and Ikr blocker, in conscious dogs with a healed myocardial infarction. 112
Alpha 1-adrenergic blockade and sudden cardiac death. 110
Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. 107
Novel human pathological mutations. Gene symbol: SCN5A. Disease: Brugada Syndrome. 106
Linee Guida. Task Force sulla Morte Cardiaca Improvvisa, Società Europea di Cardiologia. Riassunto delle raccomandazioni 106
Multiscale complexity analysis of the cardiac control identifies asymptomatic and symptomatic patients in long QT syndrome type 1. 106
[Neural mechanisms of sudden death]. 105
Electrocardiographic and genetic screening for long QT syndrome: results from a prospective study on 44,596 neonates. 103
Risk stratification in the Long-QT Syndrome 102
The LQT2 KCNH2-Q376Q splicing muation: functional characterization, molecular correction and therapeutic implication. 102
Role of common and rare variants in SCN10A: results from the Brugada syndrome QRS locus gene discovery collaborative study 102
Long QT syndrome-associated mutations in intrauterine fetal death. 102
A Molecular Link between the Sudden Infant Death Syndrome and the Long-QT Syndrome. 102
QT lungo, sindrome del 101
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes 101
A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents. 100
Mortalità infantile e morte improvvisa in culla in Lombardia 100
Sympathetic activation, ventricular repolarization and Ikr blockade: implications for the antifibrillatory efficacy of potassium channel blocking agents 100
Unexplained cardiac arrest. The need for a prospective registry. 100
Inherited cardiac arrhythmia syndrome. Role of potassium channels 99
Cardiac potassium channel dysfunction in sudden infant death syndrome. 99
Farmaci antipsicotici, QT lungo, morte improvvisa e rischio cardiovascolare. Il cardiologo incontra lo psichiatra 99
Cardiac arrhythmias of genetic origin are important contributors to Sudden Infant Death Syndrome. 98
All LQT3 patients need an ICD. True or false? 98
Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification. 98
Adrenergic Arrhythmogenesis and The Long QT syndrome 98
QT prolongation and sudden infant death syndrome - from theory to evidence. 98
Autonomic nervous system, myocardial ischemia, and malignant ventricular arrhythmias: Experimental findings 98
Ranolazine in the treatment of atrial fibrillation: Results of the dose-ranging RAFFAELLO (ranolazine in atrial fibrillation following an electrical cardioversion) study 98
A Recessive Variant of the Romano-Ward Long QT Syndrome 97
An experimental approach to the choice of antiarrhythmic therapy. 97
Rapid heart rate increase at onset of exercise predicts adverse cardiac events in patients with coronary artery disease 97
Arrhythmogenic disorders of genetic origin. Long QT Syndrome: from genetics to management. 97
[Sudden death after myocardial infarction. Prediction based on the baroreceptor reflex]. 97
[Evaluation of flecainide in the therapy of chronic ventricular arrhythmia using the acute oral load method]. 96
QT prolongation, sudden death, and sympathetic imbalance: the pendulum swings. 95
Cardiac sodium channel dysfunction in sudden infant death syndrome. 95
A novel disease gene for Brugada syndrome: sarcolemmal membrane-associated protein gene mutations impair intracellular trafficking of hNav1.5. 95
[Baroceptive reflex sensibility in non-anesthetized animals. Evaluation and comparison of 2 methods applicable to humans]. 95
Autonomic Modulation for the Management of Patients with Chronic Heart Failure 94
Baroreceptor reflexes and sudden cardiac death: experimental findings and background. 94
Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model 94
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi007-A from a Long QT Syndrome type 1 patient carrier of two common variants in the NOS1AP gene 93
Legal implications of medical guidelines. A task Force of the European Society of Cardiology 92
[Long-QT caused by drugs and torsade de pointes: a genetic basis?]. 92
Can a message from the dead save lives? 92
A common polymorphism associated with antibiotic-induced cardiac arrhythmia 92
Autonomic nervous system and arrhythmias. 92
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi002-A from a patient affected by the Jervell and Lange-Nielsen syndrome and carrier of two compound heterozygous mutations on the KCNQ1 gene 92
Individual autonomic profile contributes to the risk for life-threatening arrhythmias among KCNQ1-A341V mutation carriers 91
The ICD for the long QT syndrome: which indications, complications, and results? 91
Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population. 91
The long QT syndrome. Prospective longitudinal study of 328 families. 91
A molecular basis for the therapy of the long QT syndrome 91
Age and sex-related differences in the clinical manifestations of congenital long QT syndrome: findings from the International Prospective LQTS Registry 91
K+ channel blockade in the prevention of ventricular fibrillation in dogs with acute ischemia and enhanced sympathetic activity. 90
Sertraline treatment of major depression in patients with acute MI or unstable angina. 90
Scopolamine increases vagal tone and vagal reflexes in patients after myocardial infarction. 90
Prevalence of the congenital long-QT syndrome. 90
Atrial fibrillation requiring urgent medical care. Approach and outcome in the various departments of admission. Data from the atrial Fibrillation/flutter Italian REgistry (FIRE). 90
The genetics underlying acquired long QT syndrome: impact for genetic screening. 90
Genotype-Phenotype correlation in the Long QT Syndrome. Gene-specific triggers for life-threatening arrhythmias 89
Rapid recovery of baroreceptor reflexes in acute myocardial infarction is a marker of effective tissue reperfusion 89
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi003-A from a patient affected by an autosomal recessive form of Long QT Syndrome type 1 89
Cost-effectiveness of Neonatal ECG as a Screening for Long QT-syndrome: A Decision Analysis Approach. 88
KCNH2-K897T Is a Genetic Modifier of Latent Congenital Long-QT Syndrome. 88
Scopolamine increases vagal tone and vagal reflexes in patients after myocardial infarction 88
[Electric change of the wave T: clinical and experimental evidence of its relation to the sympathetic nervous system]. 88
Congenital long QT and short QT syndromes 88
Baroreflex sensitivity predicts long-term cardiovascular mortality after myocardial infarction even in patients with preserved left ventricular function. 88
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi005-A from a patient carrying the KCNQ1-R190W mutation 88
Totale 11.208
Categoria #
all - tutte 186.494
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 186.494


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.355 0 0 0 0 0 486 11 569 117 560 503 109
2021/20222.401 31 10 72 28 34 176 30 129 173 67 390 1.261
2022/20237.639 921 455 58 608 836 888 6 456 3.103 34 170 104
2023/20242.416 259 528 108 197 280 647 52 128 7 67 69 74
2024/20257.226 120 683 194 251 110 284 617 756 1.604 222 627 1.758
2025/20268.308 1.114 1.197 2.185 1.436 1.632 744 0 0 0 0 0 0
Totale 43.568